Special issue: frontiers in recent advances on cancer diagnosis and treatment

  • Bengt Westermark Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
  • Carl-Henrik Heldin Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden
DOI: https://doi.org/10.48101/ujms.v129.11919

Abstract

‘Of all the processes that the student of pathology is privileged to study, none is as intriguing, fascinating, and perplexing as neoplasia.’

This statement, a quote from William Boyd’s Textbook of Pathology (1961), remains as thought-provoking today as when it was first written. Over the decades since Boyd penned these words, our understanding of the molecular mechanisms underlying tumorigenesis and the development of novel therapeutic approaches have advanced at a revolutionary pace. This special issue of UJMS on cancer exemplifies the remarkable progress in cancer research, reaffirming that Boyd’s perspective on the enigmatic nature of cancer endures.

Downloads

Download data is not yet available.

References

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70. doi: 10.1016/s0092-8674(00)81683-9

2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74. doi: 10.1016/j.cell.2011.02.013

3. Strandgren C, Wiman KG. Therapeutic targeting of TP53 nonsense mutations in cancer. Ups J Med Sci. 2024;129:e10719. doi: 10.48101/ujms.v129.10719

4. Andersson L. White horses – non-coding sequences drive premature hair greying and predisposition to melanoma. Ups J Med Sci. 2024;129:e10626. doi: 10.48101/ujms.v129.10626

5. Rodrigues-Junior DM, Moustakas A. Unboxing the network among long non-coding RNAs and TGF-beta signaling in cancer. Ups J Med Sci. 2024;129:e10614. doi: 10.48101/ujms.v129.10614

6. Pietras K, Sjolund J. Cellular plasticity in the breast cancer ecosystem. Ups J Med Sci. 2024;129:e10629. doi: 10.48101/ujms.v129.10629

7. Milosevic V, Ostman A. Interactions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential. Ups J Med Sci. 2024;129:e10710. doi: 10.48101/ujms.v129.10710

8. Badillo O, Helfridsson L, Niemi J, Hellstrom M. Exploring dendritic cell subtypes in cancer immunotherapy: unraveling the role of mature regulatory dendritic cells. Ups J Med Sci. 2024;129:e10627. doi: 10.48101/ujms.v129.10627

9. Sjoberg E. Molecular mechanisms and clinical relevance of endothelial cell cross-talk in clear cell renal cell carcinoma. Ups J Med Sci. 2024;129:e10632. doi: 10.48101/ujms.v129.10632

10. Glimelius B. Recent advances in rectal cancer treatment – are we on the right track? Ups J Med Sci. 2024;129:e10537. doi: 10.48101/ujms.v129.10537

11. Falkman L, Sundin A, Skogseid B, Botling J, Bernardo Y, Wallin G, et al. Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors. Ups J Med Sci. 2024;129:e10660. doi: 10.48101/ujms.v129.10660

12. Szulzewsky F, Thirimanne HN, Holland EC. Meningioma: current updates on genetics, classification, and mouse modeling. Ups J Med Sci. 2024;129:e10579. doi: 10.48101/ujms.v129.10579

13. Takahashi-Yamashiro K, Miyazono K. Tissue clearing method in visualization of cancer progression and metastasis. Ups J Med Sci. 2024;129:e10634. doi: 10.48101/ujms.v129.10634
Published
2024-12-31
How to Cite
Westermark B., & Heldin C.-H. (2024). Special issue: frontiers in recent advances on cancer diagnosis and treatment. Upsala Journal of Medical Sciences, 129(S1), e11919. https://doi.org/10.48101/ujms.v129.11919
Issue
Vol. 129 (2024): Special issue: Frontiers in recent advances on cancer diagnosis and treatment
Section
Editorial
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain copyright of their work, with first publication rights granted to Upsala Medical Society. Read the full Copyright- and Licensing Statement.

Crossref
Scopus
Google Scholar
Europe PMC